Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Diagnostic value of contrast-enhanced ultrasound parametric imaging in breast tumors.

Yuan Z, Quan J, Yunxiao Z, Jian C, Zhu H, Liping G.

J Breast Cancer. 2013 Jun;16(2):208-13. doi: 10.4048/jbc.2013.16.2.208. Epub 2013 Jun 28.

2.

Contrast-enhanced ultrasound is helpful in the differentiation of malignant and benign breast lesions.

Zhao H, Xu R, Ouyang Q, Chen L, Dong B, Huihua Y.

Eur J Radiol. 2010 Feb;73(2):288-93. doi: 10.1016/j.ejrad.2009.05.043. Epub 2009 Jun 25.

PMID:
19559551
3.

DVP parametric imaging for characterizing ovarian masses in contrast-enhanced ultrasound.

Sha-sha H, Li H, Jie M, Gui F, Wen-jun G, Ming H, Yang Z, Qing Y.

Eur J Gynaecol Oncol. 2015;36(5):574-8.

PMID:
26513886
4.

Optimization of Region of Interest Drawing for Quantitative Analysis: Differentiation Between Benign and Malignant Breast Lesions on Contrast-Enhanced Sonography.

Nakata N, Ohta T, Nishioka M, Takeyama H, Toriumi Y, Kato K, Nogi H, Kamio M, Fukuda K.

J Ultrasound Med. 2015 Nov;34(11):1969-76. doi: 10.7863/ultra.14.10042. Epub 2015 Sep 18.

PMID:
26384607
5.

[Value of contrast-enhanced ultrasound (CEUS) in the differential diagnosis between benign and malignant renal neoplasms].

Zhang S, Wang XQ, Xin XJ, Xu Y.

Zhonghua Zhong Liu Za Zhi. 2013 May;35(5):382-5. doi: 10.3760/cma.j.issn.0253-3766.2013.05.013. Chinese.

PMID:
24054017
6.

Differentiation between benign and malignant breast tumors using kinetic features of real-time harmonic contrast-enhanced ultrasound.

Saracco A, Szabó BK, Aspelin P, Leifland K, Wilczek B, Celebioglu F, Axelsson R.

Acta Radiol. 2012 May 1;53(4):382-8. doi: 10.1258/ar.2012.110562. Epub 2012 Mar 20.

PMID:
22434928
7.

Parametric imaging with contrast-enhanced ultrasound for differentiating hepatocellular carcinoma from metastatic liver cancer.

Yue WW, Wang S, Xu HX, Sun LP, Guo LH, Bo XW, Li XL, Zhao CK, Wang D, Liu BJ.

Clin Hemorheol Microcirc. 2016 Nov 25;64(2):177-188.

PMID:
27258196
8.

Differentiating benign from malignant solid breast lesions: combined utility of conventional ultrasound and contrast-enhanced ultrasound in comparison with magnetic resonance imaging.

Du J, Wang L, Wan CF, Hua J, Fang H, Chen J, Li FH.

Eur J Radiol. 2012 Dec;81(12):3890-9. doi: 10.1016/j.ejrad.2012.09.004. Epub 2012 Oct 11.

PMID:
23062280
9.

[Value of contrast-enhanced sonography in early diagnosis of breast cancer].

Cai L, Zhang J, Song G, Chen L, Dai J.

Nan Fang Yi Ke Da Xue Xue Bao. 2013 Dec;33(12):1801-5. Chinese.

10.

Predictive model for contrast-enhanced ultrasound of the breast: Is it feasible in malignant risk assessment of breast imaging reporting and data system 4 lesions?

Luo J, Chen JD, Chen Q, Yue LX, Zhou G, Lan C, Li Y, Wu CH, Lu JQ.

World J Radiol. 2016 Jun 28;8(6):600-9. doi: 10.4329/wjr.v8.i6.600.

11.

Parametric imaging with contrast-enhanced ultrasound: usefulness for characterization of dynamic effects of microvascularization for hepatocellular carcinoma and focal nodular hyperplasia.

Zheng SG, Xu HX, Liu LN, Wang Y, Zhang YF, Guo LH, Liu C, Xu JM, Sun LP, Wu J.

Clin Hemorheol Microcirc. 2013;55(3):375-89. doi: 10.3233/CH-121652. Erratum in: Clin Hemorheol Microcirc. 2014;58(4):559.

PMID:
23271200
12.

Pharmacokinetic approach for dynamic breast MRI to indicate signal intensity time curves of benign and malignant lesions by using the tumor flow residence time.

Renz DM, Diekmann F, Schmitzberger FF, Pietsch H, Fallenberg EM, Durmus T, Huppertz A, Böttcher J, Bick U, Hamm B, Lawaczeck R.

Invest Radiol. 2013 Feb;48(2):69-78. doi: 10.1097/RLI.0b013e31827d29cf.

PMID:
23262793
13.

Perfusion curve f (t) analysis of breast cancer by contrast-enhanced ultrasonography.

Guo L, Liu ZG, Han PH, Yuan Q, He Y, Li J.

Acta Radiol. 2012 Nov 1;53(9):981-6. doi: 10.1258/ar.2012.110707. Epub 2012 Sep 11.

PMID:
22969089
14.

[Distinguishing benign and malignant lesions with time-signal intensity curve of dynamic contrast-enhanced breast MRI scanning].

Yuan HM, Yu JQ, Chu ZG, Peng LQ.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2011 Jul;42(4):556-9. Chinese.

PMID:
21866648
15.

Effect of observer experience in the differentiation between benign and malignant liver tumors after ultrasound contrast agent injection.

Quaia E, Alaimo V, Baratella E, Pizzolato R, Cester G, Medeot A, Cova MA.

J Ultrasound Med. 2010 Jan;29(1):25-36.

PMID:
20040772
16.

Differential diagnosis of nonpalpable testicular lesions: qualitative and quantitative contrast-enhanced US of benign and malignant testicular tumors.

Isidori AM, Pozza C, Gianfrilli D, Giannetta E, Lemma A, Pofi R, Barbagallo F, Manganaro L, Martino G, Lombardo F, Cantisani V, Franco G, Lenzi A.

Radiology. 2014 Nov;273(2):606-18. doi: 10.1148/radiol.14132718. Epub 2014 Jun 26.

PMID:
24968192
17.

Differentiation of focal liver lesions: usefulness of parametric imaging with contrast-enhanced US.

Anaye A, Perrenoud G, Rognin N, Arditi M, Mercier L, Frinking P, Ruffieux C, Peetrons P, Meuli R, Meuwly JY.

Radiology. 2011 Oct;261(1):300-10. doi: 10.1148/radiol.11101866. Epub 2011 Jul 11.

PMID:
21746815
18.

Evaluation of breast lesions by contrast enhanced ultrasound: qualitative and quantitative analysis.

Wan C, Du J, Fang H, Li F, Wang L.

Eur J Radiol. 2012 Apr;81(4):e444-50. doi: 10.1016/j.ejrad.2011.03.094. Epub 2011 May 25.

PMID:
21612882
19.

Dynamic Vascular Pattern (DVP), a quantification tool for contrast enhanced ultrasound.

Cui XW, Ignee A, Jedrzejczyk M, Dietrich CF.

Z Gastroenterol. 2013 May;51(5):427-31. doi: 10.1055/s-0032-1325371. Epub 2013 May 16.

PMID:
23681894
20.

The place of CEUS in distinguishing benign from malignant cervical lymph nodes: a prospective study.

Poanta L, Serban O, Pascu I, Pop S, Cosgarea M, Fodor D.

Med Ultrason. 2014 Mar;16(1):7-14.

Supplemental Content

Support Center